The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Role of ketogenic diets in neurodegenerative diseases (Alzheimer's disease and Parkinson's disease)
Open accessAbstract
The goal of this review was to assess the effectiveness of ketogenic diets on the therapy of neurodegenerative diseases. The ketogenic diet is a low-carbohydrate and fat-rich diet. Its implementation has a fasting-like effect, which brings the body into a state of ketosis. The ketogenic diet has, for almost 100 years, been used in the therapy of drug-resistant epilepsy, but current studies indicate possible neuroprotective effects. Thus far, only a few studies have evaluated the role of the ketogenic diet in the prevention of Parkinson’s disease (PD) and Alzheimer’s disease (AD). Single studies with human participants have demonstrated a reduction of disease symptoms after application. The application of the ketogenic diet to elderly people, however, raises certain concerns. Persons with neurodegenerative diseases are at risk of malnutrition, while food intake reduction is associated with disease symptoms. In turn, the ketogenic diet leads to a reduced appetite; it is not attractive from an organoleptic point of view, and may be accompanied by side effects of the gastrointestinal system. All this may lead to further lowering of consumed food portions by elderly persons with neurodegenerative diseases and, in consequence, to further reduction in the supply of nutrients provided by the diet. Neither data on the long-term application of the ketogenic diet in patients with neurodegenerative disease or data on its effects on disease symptoms are available. Further research is needed to evaluate the suitability of the ketogenic diet in the therapy of AD- or PD-affected persons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, the neuroprotective effects of the ketogenic diet have also been reported in studies, which would benefit patients with Alzheimer’s or Parkinson’s disease [42,43].”
In the citing paper
“Włodarek et al. (106) found that a ketogenic diet, which is high in fat, moderate in protein, and low in carbohydrates, has the potential to reduce neuronal degeneration, and that this specific type of nutritional intervention may provide neuroprotection.”
From Modulation of the gut–brain axis via the gut microbiota: a new era in treatment of amyotrophic lateral sclerosis (2023) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tranfield, D., Denyer, D., & Smart, P. (2003) · British Journal of Management · doi:10.1111/1467-8551.00375 · Cited by 15,386 · cited 1×
“The literature’s analyses on the ketogenic diet in the context of neurodegenerative diseases was based on the principles of a structured literature review, a tool used in developing evidence-based knowledge in a rigorous and relevant way [17].”
MethodBauer, J., Biolo, G., Cederholm, T., Cesari, M., Cruz-Jentoft, A. J., Morley, J. E., Phillips, S., Sieber, C., Stehle, P., Teta, D., et al. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.021 · Cited by 2,553 · cited 1×
“2 g of protein/kg per day, or even more if they are physically active [57].”
BackgroundJasper's Basic Mechanisms of the Epilepsies
(2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.001.0001 · Cited by 1,143
Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets
Paoli, A., Rubini, A., Volek, J. S., & Grimaldi, K. A. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.116 · Cited by 885 · cited 1×
“In consequence, there is an increased secretion of metabolism nitrogen products, so diuresis in enhanced to maintain a constant dilution of these metabolites in urine [55], while in persons with normal kidney function, it need not exert any negative effects on the body [55].”
BackgroundClinical definition of sarcopenia
Santilli, V (2014) · Clinical Cases in Mineral and Bone Metabolism · doi:10.11138/ccmbm/2014.11.3.177 · Cited by 710 · cited 1×
“Sarcopenia is a problem which affects elderly persons, and its incidence increases with age [56].”
BackgroundThe neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies
Maalouf, M., Rho, J. M., & Mattson, M. P. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.09.002 · Cited by 574 · cited 1×
“Caloric restriction also has anti-inflammatory effects; it can reduce levels of NFkB, the central component of the inflammatory process, and block the synthesis of interleukins (IL1β, IL2, IL4, IL6) and tumor necrosis factors (TNFα) and suppresses the activity of cyclooxygenase-2 (COX-2) and inducible nitric oxide syn…”
BackgroundHenderson, S. T., Vogel, J. L., Barr, L. J., Garvin, F., Jones, J. J., & Costantini, L. C. (2009) · Nutrition & Metabolism · doi:10.1186/1743-7075-6-31 · Cited by 548 · cited 2×
“A diet based on medium-chain triglycerides (MCT) was applied as a form of therapy in the 1950s [11], which led to an increase in the concentration of ketone bodies in the blood, even if carbohydrates were present in the diet; thus, this version of KD enables the production of ketone bodies without drastic changes in d…”
d -β-Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease
Kashiwaya, Y., Takeshima, T., Mori, N., Nakashima, K., Clarke, K., & Veech, R. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5440 · Cited by 535 · cited 2×
“It was shown that beta-hydroxybutyrate acts in vitro as a neuroprotective agent against the toxicity of MPTP on dopaminergic neurons [7].”
BackgroundManoharan, S., Guillemin, G. J., Abiramasundari, R. S., Essa, M. M., Akbar, M., & Akbar, M. D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8590578 · Cited by 523 · cited 1×
“Imbalance in dopamine metabolism due to oxidative stress has been recognized as a contributor to this disease [21].”
BackgroundEffects of β-hydroxybutyrate on cognition in memory-impaired adults
Reger, M. A., Henderson, S. T., Hale, C., Cholerton, B., Baker, L. D., Watson, G. S., Hyde, K., Chapman, D., & Craft, S. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00087-3 · Cited by 508
Research works printed but not linked: 4
- Conklin, 1922, Cause and treatment of epilepsy, Jam. Osteopatic. Assoc., 26, 11
- Guelpa, 1911, A lutte contre l’epilepsie par la desintoxication et par la reduction altimentaire, Rev. Ther. Med. Chir. (Paris), 78, 8
- 2012, Characteristisc of ketogenic diet and its terapeutic properties in central nevous system disorders, Annal Academiae Medicea Silesiensis, 66, 66
- Nazarewicz, 2007, Effects of high fat ketogenic diets, Bromat. Chem. Toksykol., XL, 371
Cited by
Lipids and Alzheimer’s Disease
Kao, Y.-C., Ho, P.-C., Tu, Y.-K., Jou, I.-M., & Tsai, K.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041505 · Cited by 485
“However, KD application for the elderly arouses concerns since people with neurodegenerative diseases have risks of malnutrition and KD might lead to a reduced appetite and be accompanied by gastrointestinal side effects, exacerbating any nutritional deficits [90].”
BackgroundEffects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases
Jensen, N. J., Wodschow, H. Z., Nilsson, M., & Rungby, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228767 · Cited by 446
Ketogenic Diet in Alzheimer’s Disease
Rusek, M., Pluta, R., Ułamek-Kozioł, M., & Czuczwar, S. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163892 · Cited by 319
Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease
Phillips, M. C. L., Deprez, L. M., Mortimer, G. M. N., Murtagh, D. K. J., McCoy, S., Mylchreest, R., Gilbertson, L. J., Clark, K. M., Simpson, P. V., McManus, E. J., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00783-x · Cited by 249
“This proportion is also high given that ketogenic diets are often considered unpalatable [25].”
BackgroundThe Role of Ketogenic Diet in the Treatment of Neurological Diseases
Dyńka, D., Kowalcze, K., & Paziewska, A. (2022) · Nutrients · doi:10.3390/nu14235003 · Cited by 215
Metadata
- Authors
- Włodarek, D.
- Affiliations
- Warsaw University of Life Sciences (PL)
- Corresponding author
- Włodarek, Dariusz
- ORCID
- Włodarek, Dariusz
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-01-15
- Volume
- 11
- Issue
- 1
- Pages
- 169
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6356942
- OpenAlex
- W2910859275
- Semantic Scholar
- 7d537ea1be5b6de5ff1d316704c5f868eee0291a
- Cited by
- 301
- References
- 53
- Citations by year
- 2026: 14 · 2025: 38 · 2024: 39 · 2023: 46 · 2022: 55 · 2021: 52 · 2020: 40 · 2019: 17
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- ketogenic diet, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, ketosis, neuroprotection, drug-resistant epilepsy, malnutrition, appetite suppression, gastrointestinal adverse effects, elderly patients, hypophagia
- MeSH terms
- Alzheimer Disease, Appetite, Brain, Feeding Behavior, Humans, Ketosis, Nutritional Status, Parkinson Disease, Malnutrition, Diet, Ketogenic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of ketogenic diets in neurodegenerative diseases (Alzheimer's disease and Parkinson's disease). https://app.cochat.ai/papers/10.3390/nu11010169
- The paper
- Włodarek, D. (2019). Role of ketogenic diets in neurodegenerative diseases (Alzheimer's disease and Parkinson's disease). Nutrients. https://doi.org/10.3390/nu11010169
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.